Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pentagastrin SCHEMBL30816011 | 1.00 | CCKBR (1.00) | CCKBRCCKAR | |
| Pentagastrin SCHEMBL26045 | 1.00 | CCKBR (1.00) | CCKBRCCKAR | |
| Pentagastrin SCHEMBL11108595 | 0.93 | CCKBR (0.87) | CCKBRCCKAR | |
| Pentagastrin SCHEMBL9585907 | 0.92 | CCKBR (0.84) | CCKBRCCKAR | |
| SCHEMBL11568613 | 0.92 | CCKBR (0.92) | CCKBRCCKAR | |
| SCHEMBL7717910 | 0.91 | CCKBR (0.83) | CCKBRCCKAR | |
| SCHEMBL3256052 | 0.91 | CCKBR (0.83) | CCKBRCCKAR | |
| SCHEMBL1650018 | 0.91 | CCKBR (0.83) | CCKBRCCKAR | |
| SCHEMBL3728959 | 0.88 | CCKBR (0.79) | CCKBRCCKAR | |
| SCHEMBL11272941 | 0.88 | CCKBR (0.78) | CCKBRCCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5755 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | claimed |
| US-12584110-B2 | Functional feline pancreatic cells from adipose tissue | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2026-03-24 | — | — | US | claimed |
| US-20260041716-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING WOUND REPAIR AND PREPARATION METHOD THEREOF | GWO XI STEM CELL APPLIED TECH CO LTD (TW) | 2026-02-12 | — | — | US | claimed |
| US-20260027062-A1 | IMPROVED ORAL PHARMACEUTICAL FORMULATIONS OF THERAPEUTIC PEPTIDES AND PROTEINS | CYPRUMED GMBH (AT) | 2026-01-29 | — | — | US | claimed |
| US-12533321-B2 | Polypeptide formulations for oral delivery | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2026-01-27 | — | — | US | claimed |
| EP-4601623-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2025-08-20 | — | — | EP | claimed |
| EP-4601697-A2 | A FORMULATION FOR ORAL DELIVERY OF PEPTIDES AND BIOSIMILARS FOR SYSTEMIC ABSORPTION AND METHOD OF MANUFACTURING THE SAME | NBI Biosciences Pvt Ltd (IN) | 2025-08-20 | — | — | EP | claimed |
| US-20250092356-A1 | HIGH SECRETION INSULIN-PRODUCING CELLS | GWO XI STEM CELL APPLIED TECHNOLOGY CO., LTD. (TW) | 2025-03-20 | — | — | US | claimed |
| CN-119454605-A | Composition for realizing oral absorption of polypeptide | 深圳奥礼生物科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| US-12208118-B2 | Pharmaceutical compositions for delivery of peptide | ANYA BIOPHARM INC. (CN) | 2025-01-28 | — | — | US | claimed |
| EP-0092918-B1 | CONTINUOUS RELEASE FORMULATIONS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-10-19 | — | — | EP | claimed |
| US-4767628-A | POLYLACTONE AND ACID STABLE POLYPEPTIDE | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-08-30 | — | — | US | claimed |
| EP-0225189-A2 | Targeted enteral delivery system | R.P. SCHERER CORPORATION (US) | 1987-06-10 | — | — | EP | claimed |
| EP-0115227-B1 | PEPTIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1987-03-18 | — | — | EP | claimed |
| EP-0058481-B1 | CONTINUOUS RELEASE PHARMACEUTICAL COMPOSITIONS | ZENECA LIMITED (GB) | 1986-10-01 | — | — | EP | claimed |
| EP-0166596-A2 | Biodegradable amphipathic copolymers | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1986-01-02 | — | — | EP | claimed |
| US-4548805-A | Non-invasive test for gastric acid | SACK DAVID A | 1985-10-22 | — | — | US | claimed |
| EP-0144594-A1 | Derivatives of 5H-[1]benzopyrano-[2,3-d]-pyrimidines, process for their preparation and medicines containing them, useful against gastral and duodenal lesions of the mucosa | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1985-06-19 | — | — | EP | claimed |
| US-4464363-A | HYDROXY ARYL- OR HYDROXY ARALKYL ACIDS OR SALTS | MERCK & CO., INC. (US) | 1984-08-07 | — | — | US | claimed |
| EP-0092918-A2 | Continuous release formulations | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-11-02 | — | — | EP | claimed |